| Authors: |
Li X; Department of Lymphoma and Myeloma, University of Texas (UT) MD Anderson Cancer Center, Houston, TX, USA; Lymphoid Malignancies Program, UT MD Anderson Cancer Center, Houston, TX, USA., Singhal K; Division of Oncology, Department of Medicine, Washington University School of Medicine, St. Louis, MO, USA., Deng Q; Department of Lymphoma and Myeloma, University of Texas (UT) MD Anderson Cancer Center, Houston, TX, USA., Chihara D; Department of Lymphoma and Myeloma, University of Texas (UT) MD Anderson Cancer Center, Houston, TX, USA., Russler-Germain D; Division of Oncology, Department of Medicine, Washington University School of Medicine, St. Louis, MO, USA; Siteman Cancer Center, Washington University School of Medicine, St. Louis, MO, USA., Harkins RA; Department of Lymphoma and Myeloma, University of Texas (UT) MD Anderson Cancer Center, Houston, TX, USA., Henderson J; Department of Lymphoma and Myeloma, University of Texas (UT) MD Anderson Cancer Center, Houston, TX, USA., Arita K; Department of Lymphoma and Myeloma, University of Texas (UT) MD Anderson Cancer Center, Houston, TX, USA., Kizhakeyil A; Department of Lymphoma and Myeloma, University of Texas (UT) MD Anderson Cancer Center, Houston, TX, USA., Sun R; Department of Biostatistics, UT MD Anderson Cancer Center, Houtson, TX, USA., Lakra P; Department of Lymphoma and Myeloma, University of Texas (UT) MD Anderson Cancer Center, Houston, TX, USA., Hussein U; Department of Lymphoma and Myeloma, University of Texas (UT) MD Anderson Cancer Center, Houston, TX, USA., Foltz JA; Division of Oncology, Department of Medicine, Washington University School of Medicine, St. Louis, MO, USA; Siteman Cancer Center, Washington University School of Medicine, St. Louis, MO, USA., Wilson A; Department of Lymphoma and Myeloma, University of Texas (UT) MD Anderson Cancer Center, Houston, TX, USA., Schmidt E; Division of Oncology, Department of Medicine, Washington University School of Medicine, St. Louis, MO, USA., Nizamuddin I; Division of Oncology, Department of Medicine, Washington University School of Medicine, St. Louis, MO, USA., Dinh T; Department of Lymphoma and Myeloma, University of Texas (UT) MD Anderson Cancer Center, Houston, TX, USA., Kesaraju A; Division of Oncology, Department of Medicine, Washington University School of Medicine, St. Louis, MO, USA., Hamilton MP; Department of Lymphoma and Myeloma, University of Texas (UT) MD Anderson Cancer Center, Houston, TX, USA., Allen C; Department of Pediatrics, Baylor College of Medicine, Texas Children's Cancer Center, Houston, TX, USA., Gandhi MK; Mater Hospital, University of Queensland, Brisbane, QLD, Australia., Tobin J; Mater Hospital, University of Queensland, Brisbane, QLD, Australia., Jiang A; Centre for Lymphoid Cancer, BC Cancer, Vancouver, BC, Canada., Hilton L; Centre for Lymphoid Cancer, BC Cancer, Vancouver, BC, Canada., Scott DW; Centre for Lymphoid Cancer, BC Cancer, Vancouver, BC, Canada; Department of Pathology and Laboratory Medicine, The University of British Columbia, Vancouver, BC, Canada; Division of Medical Oncology, Department of Medicine, The University of British Columbia, Vancouver, BC, Canada., Vega F; Department of Hematopathology, UT MD Anderson Cancer Center, Houston, TX, USA., Flowers CR; Department of Lymphoma and Myeloma, University of Texas (UT) MD Anderson Cancer Center, Houston, TX, USA; Lymphoid Malignancies Program, UT MD Anderson Cancer Center, Houston, TX, USA., Westin JR; Department of Lymphoma and Myeloma, University of Texas (UT) MD Anderson Cancer Center, Houston, TX, USA; Lymphoid Malignancies Program, UT MD Anderson Cancer Center, Houston, TX, USA., Griffith OL; Division of Oncology, Department of Medicine, Washington University School of Medicine, St. Louis, MO, USA; Siteman Cancer Center, Washington University School of Medicine, St. Louis, MO, USA; McDonnell Genome Institute, Washington University School of Medicine, St. Louis, MO, USA; Department of Genetics, Washington University School of Medicine, St. Louis, MO, USA., Fehniger TA; Division of Oncology, Department of Medicine, Washington University School of Medicine, St. Louis, MO, USA; McDonnell Genome Institute, Washington University School of Medicine, St. Louis, MO, USA., Griffith M; Division of Oncology, Department of Medicine, Washington University School of Medicine, St. Louis, MO, USA; Siteman Cancer Center, Washington University School of Medicine, St. Louis, MO, USA; McDonnell Genome Institute, Washington University School of Medicine, St. Louis, MO, USA; Department of Genetics, Washington University School of Medicine, St. Louis, MO, USA., Green MR; Department of Lymphoma and Myeloma, University of Texas (UT) MD Anderson Cancer Center, Houston, TX, USA; Lymphoid Malignancies Program, UT MD Anderson Cancer Center, Houston, TX, USA; Department of Genomic Medicine, UT MD Anderson Cancer Center, Houston, TX, USA. Electronic address: mgreen5@mdanderson.org. |
